Summary & Overview
CPT 90758: Live Intramuscular Vaccine for Zaire Ebolavirus
CPT code 90758 denotes a live intramuscular vaccine for protection against Zaire ebolavirus. As an Ebola vaccine code, it documents administration of a live-attenuated immunization typically provided in outpatient and public health clinic settings. Nationally, codes for emerging infectious disease vaccines carry importance for public health preparedness, tracking immunization uptake, and aligning coverage policies across major payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for 90758, typical sites of service, common modifiers and coding considerations, and the types of benchmarks and policy updates that inform payer coverage and claims processing. The publication summarizes coding practice implications for billing teams and revenue cycle staff, highlights areas where payer policies commonly differ, and outlines what documentation is typically needed to support claims for vaccine administration.
Where specific payer policy details or utilization benchmarks are not provided in the input, the text notes that those data are not available and focuses on the clinical and billing description of the vaccine code.
Billing Code Overview
CPT code 90758 represents a live vaccine product administered intramuscularly to protect against Zaire ebolavirus. This is a preventive immunization delivered as a live-attenuated vaccine designed to stimulate an immune response against Ebola virus disease caused by the Zaire ebolavirus species.
-
Service type: Vaccination / immunization (live vaccine)
-
Typical site of service: Outpatient clinic, public health clinic, vaccination center, or other ambulatory care settings where intramuscular vaccines are routinely administered.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 30-year-old laboratory research technician is scheduled to receive a live, intramuscular Ebola Zaire vaccine (90758) prior to beginning work in a high-containment viral research facility. The patient presents to an outpatient occupational health clinic for pre-employment immunization screening. The clinical workflow includes verification of immunization history and contraindications (pregnancy status, immunocompromise, allergy to vaccine components), informed consent discussion, and documentation of lot number and site of intramuscular administration (typically deltoid). Vital signs and a brief exam are completed to confirm fitness for vaccination. Post-vaccination, the patient is observed for 15–30 minutes for immediate adverse reactions; vaccine administration details and any patient education are recorded in the electronic medical record and the facility’s immunization registry. Billing uses 90758 for the live Zaire ebolavirus intramuscular vaccine; appropriate diagnosis pointers and any applicable modifiers are appended per payer requirements.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when vaccine administration required substantially greater work or additional counseling beyond typical vaccine visit, documented in record. |